Condensed Consolidated Statements of Equity (Unaudited) - USD ($) $ in Thousands		Cross Currency Interest Rate Contract [Member] Common Stock [Member]	Cross Currency Interest Rate Contract [Member] Additional Paid-in Capital [Member]	Cross Currency Interest Rate Contract [Member] Treasury Stock [Member]	Cross Currency Interest Rate Contract [Member] Retained Earnings [Member]	Cross Currency Interest Rate Contract [Member] AOCI Attributable to Parent [Member]	Cross Currency Interest Rate Contract [Member] Parent [Member]	Cross Currency Interest Rate Contract [Member] Noncontrolling Interest [Member]	Cross Currency Interest Rate Contract [Member]	Common Stock Outstanding [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Parent [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2020										55,983,000
Balance at Dec. 31, 2020											$ 56	$ 1,262,446	$ 0	$ 550,103	$ (6,620)	$ 1,805,985	$ 135,452	$ 1,941,437
Stock-based compensation											0	2,097	0	0	0	2,097	0	2,097
Exercise of stock-based awards by employees and directors (in shares)	[1]									1,000
Exercise of stock-based awards by employees and directors	[1]										0	0	0	0	0	0	0	0
Stock issuance costs reimbursement											0	285	0	0	0	285	0	285
Cash paid to noncontrolling interest											0	0	0	0	0	0	(3,898)	(3,898)
Cash dividend declared											0	0	0	(6,718)	0	(6,718)	0	(6,718)
Net income											0	0	0	15,259	0	15,259	2,290	17,549
Change in foreign currency translation adjustments											0	0	0	0	(1,253)	(1,253)	(573)	(1,826)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment											0	0	0	0	3,755	3,755	0	3,755
Change in respect of derivative instruments designated for cash flow hedge		$ 0	$ 0	$ 0	$ 0	$ (2,798)	$ (2,798)	$ 0	$ (2,798)
Other											0	0	0	0	16	16	0	16
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)											0	0	0	0	(20)	(20)	0	(20)
Balance (in shares) at Mar. 31, 2021										55,984,000
Balance at Mar. 31, 2021											56	1,264,828	0	558,644	(6,920)	1,816,608	133,271	1,949,879
Balance (in shares) at Dec. 31, 2020										55,983,000
Balance at Dec. 31, 2020											56	1,262,446	0	550,103	(6,620)	1,805,985	135,452	1,941,437
Change in foreign currency translation adjustments																		(1,410)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment																		2,521
Change in respect of derivative instruments designated for cash flow hedge																		(2,600)
Other																		33
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)																		(11)
Balance (in shares) at Jun. 30, 2021										55,997,000
Balance at Jun. 30, 2021											56	1,267,451	0	565,222	(7,646)	1,825,083	134,772	1,959,855
Balance (in shares) at Mar. 31, 2021										55,984,000
Balance at Mar. 31, 2021											56	1,264,828	0	558,644	(6,920)	1,816,608	133,271	1,949,879
Stock-based compensation											0	2,623	0	0	0	2,623	0	2,623
Exercise of stock-based awards by employees and directors (in shares)	[1]									13,000
Exercise of stock-based awards by employees and directors	[1]										0	0	0	0	0	0	0	0
Cash paid to noncontrolling interest											0	0	0	0	0	0	(426)	(426)
Cash dividend declared											0	0	0	(6,448)	0	(6,448)	0	(6,448)
Net income											0	0	0	13,026	0	13,026	1,795	14,821
Change in foreign currency translation adjustments											0	0	0	0	284	284	132	416
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment											0	0	0	0	(1,234)	(1,234)	0	(1,234)
Change in respect of derivative instruments designated for cash flow hedge		0	0	0	0	198	198	0	198									198
Other											0	0	0	0	17	17	0	17
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)											0	0	0	0	9	9	0	9
Balance (in shares) at Jun. 30, 2021										55,997,000
Balance at Jun. 30, 2021											56	1,267,451	0	565,222	(7,646)	1,825,083	134,772	1,959,855
Balance (in shares) at Dec. 31, 2021										56,056,000
Balance at Dec. 31, 2021											56	1,271,925	0	585,209	(2,191)	1,854,999	143,462	1,998,461
Stock-based compensation											0	2,814	0	0	0	2,814	0	2,814
Exercise of stock-based awards by employees and directors (in shares)	[1]									16,000
Exercise of stock-based awards by employees and directors	[1]										0	99	0	0	0	99	0	99
Cash paid to noncontrolling interest											0	0	0	0	0	0	(3,088)	(3,088)
Cash dividend declared											0	0	0	(6,727)	0	(6,727)	0	(6,727)
Net income											0	0	0	18,430	0	18,430	4,105	22,535
Change in foreign currency translation adjustments											0	0	0	0	(857)	(857)	(299)	(1,156)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment											0	0	0	0	3,902	3,902	0	3,902
Change in respect of derivative instruments designated for cash flow hedge		0	0	0	0	(1,905)	(1,905)	0	(1,905)
Other											0	0		0	15	15	0	15
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)											0	0	0	0	(101)	(101)	0	(101)
Balance (in shares) at Mar. 31, 2022										56,072,000
Balance at Mar. 31, 2022											56	1,274,838	0	596,912	(1,137)	1,870,669	144,180	2,014,849
Balance (in shares) at Dec. 31, 2021										56,056,000
Balance at Dec. 31, 2021											56	1,271,925	0	585,209	(2,191)	1,854,999	143,462	1,998,461
Change in foreign currency translation adjustments																		(4,615)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment																		5,445
Change in respect of derivative instruments designated for cash flow hedge																		(4,000)
Other																		30
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)																		41
Balance (in shares) at Jun. 30, 2022										55,934,000
Balance at Jun. 30, 2022											56	1,253,242	(17,964)	601,441	(4,148)	1,832,627	146,667	1,979,294
Balance (in shares) at Mar. 31, 2022										56,072,000
Balance at Mar. 31, 2022											56	1,274,838	0	596,912	(1,137)	1,870,669	144,180	2,014,849
Stock-based compensation											0	2,999	0	0	0	2,999	0	2,999
Exercise of stock-based awards by employees and directors (in shares)	[1]									121,000
Exercise of stock-based awards by employees and directors	[1]										0	(57)	0	0	0	(57)	0	(57)
Cash paid to noncontrolling interest											0	0	0	0	0	0	(140)	(140)
Cash dividend declared											0	0	0	(6,731)	0	(6,731)	0	(6,731)
Net income											0	0	0	11,260	0	11,260	3,470	14,730
Change in foreign currency translation adjustments											0	0	0	0	(2,616)	(2,616)	(843)	(3,459)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment											0	0	0	0	1,543	1,543	0	1,543
Change in respect of derivative instruments designated for cash flow hedge		$ 0	$ 0	$ 0	$ 0	$ (2,095)	$ (2,095)	$ 0	$ (2,095)									(2,095)
Other											0	0	0	0	15	15	0	15
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)											0	0	0	0	142	142	0	$ 142
Purchase of treasury stock (in shares)										(259,000)								(258,667)
Purchase of treasury stock											0	0	(17,964)	0	0	(17,964)	0	$ (17,964)
Purchase of capped call instruments											0	(24,538)	0	0	0	(24,538)	0	(24,538)
Balance (in shares) at Jun. 30, 2022										55,934,000
Balance at Jun. 30, 2022											$ 56	$ 1,253,242	$ (17,964)	$ 601,441	$ (4,148)	$ 1,832,627	$ 146,667	$ 1,979,294

[1] Resulted in an amount lower than $1 thousand.